Key result
Unaffordability of treatment was a strong independent predictor of nonadherence to antihypertension medications, increasing the odds of nonadherence by over twofold (OR 2.25).
Why the study?
Medication nonadherence causes poor health outcomes, frequent complications, and high economic impact, prompting assessment of determinants of adherence in hypertensive patients.
What are the determinants of adherence to antihypertension medications among patients with hypertension in Pakistan?
Cross-Sectional (n=450)
No
What are the determinants of adherence to antihypertension medications among patients with hypertension in Pakistan?
Odds Ratio: 2.25 (95% CI 1.46–3.48)
p-value: p=0.002
Unaffordability, female sex, and long waiting times are significant barriers to antihypertension medication adherence in Pakistan, while adequate counseling and education improve adherence.
No takes yet. Share an insight, caveat, or question.
Unaffordability was associated with antihypertensive nonadherence; leaves open whether cost interventions improve adherence in similar settings.
Noreen et al. (2023) conducted a cross-sectional in Hypertension (n=450). Unaffordability of treatment vs. Affordability of treatment was evaluated on Nonadherence to antihypertension medications (OR 2.25, 95% CI 1.46-3.48, p=0.002). Unaffordability of treatment was a strong independent predictor of nonadherence to antihypertension medications, increasing the odds of nonadherence by over twofold (OR 2.25).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: